Stock info Eli Lilly | Filter  Basic-Info

Stock: Eli Lilly (US broad), ISIN: US5324571083

Last Price 799.57 Max Price 929.72
Min Price 684.43 1 Year return 3.57
Sector Health Care Subsector Pharmaceuticals
Annual report 2017

Loading...

Contact info:Street: Lilly Corporate CenterZip Code: 46285City: IndianapolisCountry: USAPhone: 3172762000Website: www.lilly.comCEO: John C. LechleiterCFO: Derica W. Rice

Sector Review Eli Lilly

Loading...
Year Turnover Total sector Market share
2019 19,910 474,848 4.19 %
2020 20,093 469,560 4.28 %
2021 24,911 566,739 4.40 %
2022 26,669 640,095 4.17 %
2023 30,921 590,728 5.23 %

Advice Eli Lilly

No Records Found




News Eli Lilly

Analysts: more sales Eli Lilly

Tomorrow the American company Eli Lilly will publish its past quarter results. Over the current book year the total revenue from the company in Indianapolis will be 28.34 billion USD (consensus estimates). This is slightly more than 2021's revenue of 28.32 billion...

Analysts expect over 2021 rising revenue Eli Lilly

Tomorrow the American Eli Lilly will publish its past quarters figures. Over the current book year the total revenu from the company based in Indianapolis will be 27.69 billion USD (consensus estimates). This is quite more than 2020's revenue of 24.54 billion USD....

Lilly's migraine med approved in Canada for episodic cluster headache

Eli Lilly and Company (LLY -0.5%) has announced that its monoclonal antibody therapy Emgality (galcanezumab) has received approval in Canada as a treatment for episodic cluster headache. It intends to reduce the frequency of attacks throughout a clusterperiod...

Eli Lilly Partners with Blacksmith Medicines in $300mn Seed Funding Deal

California-based biotech company Blacksmith Medicines announced on it had secured a multimillion-dollar seed funding deal from Eli Lilly It has entered into a research collaboration with the Indianapolis-based pharmaceutical giant to advance human metalloenzyme...

Eli Lilly huge outperformer in American pharmaceutical sector

Thanks to the huge profit of 10 percent since begin this year it's one of the best shares of the pharmaceutical sector. Momentum pharmaceutical sector On average the sector trades now at 351 times the earnings per share. The sector trades at 41,39 times the book...

Annual reports Eli Lilly

2017 2018 2019 2020 2021

Profile Eli Lilly

Lilly (Eli) & Co.

(US5324571083)/ LLY

The past year was a relatively good year for Lilly (Eli) & Co. investors

The stock lost over the past 12 months at around 15 percent. Over the period from December 2011 till December 2016 the stock rose on average 77 percent. Lilly (Eli) & Co. 's revenues between 2011 and 2015 were quite similar and moved between 22,6 billion dollars and 19,96 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 4,35 billion dollars and 2,41 billion dollars.

Lilly (Eli) & Co. 's head office is based in Indianapolis. Lilly (Eli) & Co. 's core business is the pharmaceutical sector. John C. Lechleiter is operating by ' CEO. Derica W. Rice is financially responsible for the company as CFO. The past 10 years the (international) industry gained at around 75 percent. Over the past 5 years the sector is 147 percent higher.

Over the past 5 years the American company paid out dividends. On average the Lilly (Eli) & Co. stock yielded a delivered a dividend yield of around 9,86 percent over the past 5 years. Over the past 5 years Lilly (Eli) & Co. raised her dividends share each year. Based on the raising dividend payments Lilly (Eli) & Co. can be seen as a kind of dividend aristocrat.

Lilly (Eli) & Co. financed with relatively low debt

At the end of 2015 the pharmaceutical company's balance sheet equaled 35,57 billion dollars. Last year the total debt of the company was 21 billion dollars. This equals around 59,03 percent of the total balance sheet. The American company's price/earnings-ratio was 21. So the market valued the stock at 21 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 92,01 billion dollars. At the end of 2015 around 1,11 billion stocks were listed.

All the annual reports of Lilly (Eli) & Co. are available here. More information about Lilly (Eli) & Co. can be found it's website. .


Results Eli Lilly

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Eli Lilly

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Eli Lilly

Details
2016
2017
2018
2019
2020
Price
73.55
84.46
115.72
131.43
168.84
Eps
2.45
-0.16
2.73
7.93
5.56
Price/earnings-ratio
30.02
-527.88
42.39
16.57
143.81
Dividend
1.94
1.73
1.96
2.30
2.42
Dividend %
2.64 %
2.05 %
1.69 %
1.75 %
0.30 %
Payout %
0.79
-10.81
0.72
0.29
0.44
Book value
12.10
8.78
8.10
2.43
4.83
Market to book
0.16
0.10
0.07
0.02
0.01
Cashflow per stock
4.19
4.26
4.55
4.51
5.56
Stocks
1,101
1,100
1,058
958
957
Market Cap
80.969.36
92.906.68
122.390.10
125.847.64
764.860.67

Dividend Eli Lilly


Price info Eli Lilly

Date
Price
23 Oct 2025
799.57
18 Oct 2025
802.83
09 Oct 2025
845.72
03 Oct 2025
819.85
30 Sep 2025
726.51
22 Sep 2025
751.99
16 Sep 2025
748.19
08 Sep 2025
738.64
01 Sep 2025
732.58
21 Aug 2025
705.44
15 Aug 2025
684.43
07 Aug 2025
746.37
23 Jul 2025
776.44
18 Jul 2025
771.71
17 Jul 2025
761.50
16 Jul 2025
789.80
15 Jul 2025
771.75
14 Jul 2025
799.34
11 Jul 2025
793.01
10 Jul 2025
790.65
09 Jul 2025
786.92
08 Jul 2025
777.66
07 Jul 2025
772.87
03 Jul 2025
780.67
02 Jul 2025
779.28
01 Jul 2025
775.90
30 Jun 2025
779.53
27 Jun 2025
775.45
26 Jun 2025
795.12
25 Jun 2025
792.30